Carlos Caldas

机构：Hebrew University of Jerusalem, The University of Texas at Austin · ORCID：0000-0003-3547-1489

发表论文 1356 篇 · 总被引 128968 次 · h-index 159

代表论文

• Loss of IDH1 and IDH2 mutations during the evolution of metastatic chondrosarcoma (2025 · Genome biology · 被引 3)
• The tumor microenvironment of 14,837 breast cancers is associated with clinical outcome independently of genomic subtypes (2025 · Cell Reports Medicine · 被引 2)
• Enhanced prediction of breast cancer patient response to chemotherapy by integrating deconvolved expression patterns of immune, stromal and tumor cells (2025 · Cancer Letters · 被引 1)
• Data from PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2− Breast Cancer: Clinical and Circulating Tumor DNA Results (2026)
• Supplementary Data1 from PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2− Breast Cancer: Clinical and Circulating Tumor DNA Results (2026)
• Real-time cell viability monitoring for high-throughput drug screening using tumor xenograft-derived cells (2026 · Cell Reports Methods)